pefloxacin has been researched along with Liver Diseases in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 4 (80.00) | 18.2507 |
2000's | 1 (20.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Khlebnikov, EP; Kubyshkin, VA; Terekhova, RP; Vishnevskiĭ, VA | 1 |
Bressolle, F; Galtier, M; Gonçalves, F; Gouby, A | 1 |
Csiba, A; Ludwig, E; Székely, E | 1 |
Bressolle, F; de la Coussaye, JE; Dubois, A; Eledjam, JJ; Galtier, M; Gény, F; Gomeni, R; Joubert, P; Raffanel, C; Saissi, G | 1 |
Bruno, R; Frydman, A; Gaillot, J; Iliadis, A; Le Roux, Y; Montay, G; Rosier, P | 1 |
1 review(s) available for pefloxacin and Liver Diseases
Article | Year |
---|---|
Pefloxacin clinical pharmacokinetics.
Topics: Absorption; Age Factors; Anti-Infective Agents; Bacteria, Aerobic; Bacteria, Anaerobic; Body Fluids; Drug Interactions; Drug Resistance, Microbial; Humans; Kidney Diseases; Liver Diseases; Pefloxacin; Tissue Distribution | 1994 |
1 trial(s) available for pefloxacin and Liver Diseases
Article | Year |
---|---|
[Clinico-pharmacologic studies on pefloxacin].
Topics: Administration, Oral; Aged; Aged, 80 and over; Aging; Diuresis; Drug Evaluation; Female; Humans; Kidney Failure, Chronic; Liver Diseases; Male; Middle Aged; Pefloxacin | 1994 |
3 other study(ies) available for pefloxacin and Liver Diseases
Article | Year |
---|---|
[Clinical and laboratory investigation of pefloxacin used prophylactically in operations on the liver].
Topics: Adult; Aged; Anti-Infective Agents; Bacterial Infections; Echinococcosis, Hepatic; Female; Fungi; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Injections, Intravenous; Liver Diseases; Liver Neoplasms; Male; Middle Aged; Mycoses; Pefloxacin; Postoperative Complications; Treatment Outcome | 2009 |
Multiple-dose pharmacokinetics of pefloxacin in patients with hepatocellular deficiency.
Topics: Adult; Aged; Aged, 80 and over; Drug Administration Schedule; Drug Tolerance; Female; Gram-Negative Bacteria; Humans; Liver Diseases; Male; Microbial Sensitivity Tests; Middle Aged; Pefloxacin | 1993 |
Evaluation of Bayesian estimation to discriminate subpopulations of patients with altered pharmacokinetics using fragmentary data: a pilot study with pefloxacin.
Topics: Adult; Bayes Theorem; Female; Half-Life; Humans; Kidney Diseases; Liver Cirrhosis, Alcoholic; Liver Diseases; Male; Pefloxacin; Pilot Projects; Regression Analysis | 1991 |